Abstract
Parvovirus B19 is notoriously a cause of normocytic anaemia in patients in an immunocompromised state, more so than in patients without prior disease. It is increasingly prevalent in children and adults in an HIV-induced immunocompromised state, and its presentation may be varied. Red-cell aplasia and normocytic anaemia are common presenting derangements found. Here, we note the typical presentation of red-cell aplasia re-entering healthcare, with a dire effect on the quality of life of this patient.
Publisher
South African Medical Association NPC
Reference17 articles.
1. Sim JY, Chang LY, Chen JM, et al. Human parvovirus B19 infection in patients with or without underlying diseases. J Microbiol Immunol Infect 2019;52(4):534-541. https://doi.org/10.1016/j. jmii.2019.05.009
2. Woolf AD, Campion GV, Chishick A, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989;149(5):1153-1156.
3. Nasir IA, Medugu T, Dangana A. Human parvovirus B19-associated hematopathy in HIV disease: Need for clinicopathological revisit. J Biomed Res 2018;32(1):1-2. https://doi.org/10.7555/JBR.32.2017010 4. Clarke J, Lee JD. Primary human parvovirus B19 infection in an HIV-infected patient on highly active
4. antiretroviral therapy. Sex Transm Infect 2003;79(4):336. https://doi.org/10.1136/sti.79.4.336
5. Wilson D. Haematology. In: Maartens G, Cotton M, Wilson D, Venter F, Meyers T, Bekker L (editors). Oxford Handbook of HIV Medicine. Third ed. Johannesburg: Oxford University Press Southern